Get Rid Of Xarelto Lawsuit Once And For All

Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical organizations, like the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to complete so might be grounds for compensation. Our lawyers are functioning difficult to have those hurt by the drug the compensation they're entitled to.

While bleeding is really a typical complication linked with anticoagulants, it has been alleged that Xarelto is much more hazardous than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, individuals might be at risk for irreversible bleeding issues, which includes life-threatening internal and gastrointestinal hemorrhaging.

If you or even a loved one particular suffered a critical bleeding event after taking Xarelto, you might have legal recourse. For more details, make contact with us these days to have your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in situations of death, funeral expenses. Moreover, they are seeking punitive damages, which are normally awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege severe and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of please click the next website drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for much more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.